0B68 McGettigan, James P. - Thomas Jefferson University - Thomas Jefferson University
jpm001

James P. McGettigan, PhD

Contact Dr. McGettigan

1020 Locust Street
Jefferson Alumni Hall, Room 466
Philadelphia, PA 19107

(215) 503-4629
(215) 923-7144 fax

Most Recent Peer-reviewed Publications

  1. Reinvestigating the role of igM in rabies virus postexposure vaccination
  2. B cell infection and activation by rabies virus-based vaccines
  3. Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses
  4. Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity
  5. Experimental rabies vaccines for humans
  6. Characterization of a single-cycle rabies virus-based vaccine vector
  7. The cell biology of rabies virus: Using stealth to reach the brain
  8. Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge
  9. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates
  10. Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity
  11. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
  12. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway
  13. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease
  14. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice
  15. Rabies virus glycoprotein as a carrier for anthrax protective antigen
  16. siRNA targeting Vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects
  17. Enhanced humoral HIV-1-specifc immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2
  18. Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach
  19. Rabies virus nucleoprotein as a carrier for foreign antigens
  20. Erratum: Budding of PPxY-Containing Rhabdoviruses Is Not Dependent on Host Proteins TSG101 and VPS4A (Journal of Virology (2004) 78, 6 (2657-2665))
0